Market Overview

UPDATE: Stifel Nicolaus Raises PT to $117 on Stericycle Following Solid Q4

Share:
Related SRCL
Lightning Round: Jim Cramer Gives His Opinion On Under Armour, Weight Watchers And More
Earnings Scheduled For August 3, 2017

Stifel Nicolaus reiterated its Buy rating on Stericycle (NASDAQ: SRCL) and raised the price target from $102.00 to $117.00.

Stifel Nicolaus commented, "SRCL posted another solid quarter and raised guidance again. Revenue and EPS were ahead of estimates, though FCF came in within the expected range. We believe SRCL has largely completed the platform acquisitions it was making in the Patient Communications space that were weighing on company margins (they were declining), and margins have improved in each of the last two quarters."

Stericycle closed at $95.12 on Wednesday.

Latest Ratings for SRCL

DateFirmActionFromTo
Jun 2017BMO CapitalInitiates Coverage OnMarket Perform
May 2017BairdDowngradesNeutralUnderperform
Apr 2017BarclaysInitiates Coverage OnOverweight

View More Analyst Ratings for SRCL
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Price Target Analyst Ratings

 

Related Articles (SRCL)

View Comments and Join the Discussion!